Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Monte Rosa Therapeutics (GLUE) Other Operating Expenses (2024 - 2025)

Historic Other Operating Expenses for Monte Rosa Therapeutics (GLUE) over the last 2 years, with Q1 2025 value amounting to $59000.0.

  • Monte Rosa Therapeutics' Other Operating Expenses changed N/A to $59000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $59000.0, marking a year-over-year change of. This contributed to the annual value of $24000.0 for FY2023, which is 7798.17% down from last year.
  • As of Q1 2025, Monte Rosa Therapeutics' Other Operating Expenses stood at $59000.0.
  • Monte Rosa Therapeutics' Other Operating Expenses' 5-year high stood at $59000.0 during Q1 2025, with a 5-year trough of $24000.0 in Q2 2023.